Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06974279 · ClinicalTrials.gov registry record · NA

Post-Stroke Aphasia TMS

A NA study of Stroke and Aphasia, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06974279 is a NA study of Stroke and Aphasia that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 50 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06974279, a NA study of Stroke and Aphasia, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The investigator proposes to examine the effects of excitatory transcranial magnetic stimulation (TMS) combined with semantic feature analysis (SFA) language therapy to improve word-finding abilities in stroke survivors with aphasia (SWA).

Interventions

  • DEVICE Precision TMS with SFA
  • DEVICE Control TMS with SFA

Study Locations (1)

Wisconsin

  • Medical College of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-09-01
Est. Completion 2036-12-31
Phase NA

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT06974279

The ClinicalTrials.gov registry entry for NCT06974279 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Precision TMS with SFA is the first listed.

NCT06974279 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06974279 about?

NCT06974279 is a clinical study titled "Post-Stroke Aphasia TMS". The investigator proposes to examine the effects of excitatory transcranial magnetic stimulation (TMS) combined with semantic feature analysis (SFA) language therapy to improve word-finding abilities in stroke survivors with aphasia (SWA).

What is the current status of trial NCT06974279?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-01. Estimated completion is 2036-12-31.

What conditions does trial NCT06974279 study?

This clinical trial studies the following conditions: Stroke, Aphasia, Language.

What interventions are being tested in trial NCT06974279?

The interventions under investigation include: Precision TMS with SFA (DEVICE), Control TMS with SFA (DEVICE).

Who is sponsoring clinical trial NCT06974279?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06974279 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.